Steven M Ginsburg, DO | |
402 Mcfarlan Rd, Kennett Square, PA 19348-2453 | |
(610) 444-5678 | |
(610) 444-1738 |
Full Name | Steven M Ginsburg |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 43 Years |
Location | 402 Mcfarlan Rd, Kennett Square, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306926837 | NPI | - | NPPES |
0012657350003 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OS007049E (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Penn Medicine Home Health | Bala cynwyd, PA | Home health agency |
Chester County Hospital | West chester, PA | Hospital |
Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Clinical Care Associates Of The University Of Pennsylvania Health | 4688588866 | 517 |
News Archive
HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.
In the first large, observational study with a control group in England and Wales, research funded by the NIHR Maudsley Biomedical Research Centre has found that Community Treatment Orders are associated with an increased risk of readmission as well as increased time spent in psychiatric hospitals, contrary to results from previous uncontrolled studies.
nContact Surgical, Inc., a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias.
Celgene Corporation today announced the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee will hold a review of the Company's new drug application (NDA) for pomalidomide at its meeting on November 8, 2012.
A.P. Pharma, a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million.
› Verified 2 days ago
Entity Name | Clinical Care Associates Of The University Of Pennsylvania Health |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972682995 PECOS PAC ID: 4688588866 Enrollment ID: O20031113000301 |
News Archive
HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.
In the first large, observational study with a control group in England and Wales, research funded by the NIHR Maudsley Biomedical Research Centre has found that Community Treatment Orders are associated with an increased risk of readmission as well as increased time spent in psychiatric hospitals, contrary to results from previous uncontrolled studies.
nContact Surgical, Inc., a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias.
Celgene Corporation today announced the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee will hold a review of the Company's new drug application (NDA) for pomalidomide at its meeting on November 8, 2012.
A.P. Pharma, a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Steven M Ginsburg, DO 402 Mcfarlan Rd, Kennett Square, PA 19348-2453 Ph: (610) 444-5678 | Steven M Ginsburg, DO 402 Mcfarlan Rd, Kennett Square, PA 19348-2453 Ph: (610) 444-5678 |
News Archive
HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.
In the first large, observational study with a control group in England and Wales, research funded by the NIHR Maudsley Biomedical Research Centre has found that Community Treatment Orders are associated with an increased risk of readmission as well as increased time spent in psychiatric hospitals, contrary to results from previous uncontrolled studies.
nContact Surgical, Inc., a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias.
Celgene Corporation today announced the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee will hold a review of the Company's new drug application (NDA) for pomalidomide at its meeting on November 8, 2012.
A.P. Pharma, a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million.
› Verified 2 days ago
Peter Fabulian, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Marshall Street, Kennett Square, PA 19348 Phone: 610-444-4992 Fax: 610-444-7425 | |
Dr. Swarnalatha Neema, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 731 West Cypress St, Kennett Square, PA 19348 Phone: 610-444-7550 Fax: 610-444-4656 | |
Joseph A Greco, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 731 W Cypress St, Kennett Square, PA 19348 Phone: 610-444-7550 Fax: 610-444-4656 | |
Dr. Paul Yerkes, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 413 W Cypress St, Kennett Square, PA 19348 Phone: 610-612-9283 | |
Thomas Santamaria, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 830 W Cypress St, Kennett Square, PA 19348 Phone: 610-444-8084 Fax: 610-444-8233 | |
Dr. Faye P Meyers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 731 W Cypress St, Kennett Square, PA 19348 Phone: 610-444-7550 | |
Michael Andrew Welsh, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 687 Unionville Rd, Kennett Square, PA 19348 Phone: 610-444-4469 |